Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
ahdQw9ZM0J4WpY0B
